16 completed, 6 recruiting, 4 unknown, 3 active not recruiting. 9 Not applicable, 8 Phase 2, 5 Phase 1, 2 Phase 3, 1 Early Phase 1.
Follow HIV I Infection: new trials by email Literature Review of HIV I Infection trials Research Report on HIV I Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals Maraviroc, Dolutegravir, Dendritic Cell Vaccine - Hiv, HIV I Infection | Phase 2 | Recruiting | Federal University of São Paulo | 70 | 2026-07-15 | 2026-08-19 |
| Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France Lenacapavir Injection - HIV I Infection | Recruiting | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 80 | 2025-03-03 | 2025-05-22 | |
| Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset Dorsogluteal intramuscular injection - HIV I Infection, Injection Pain | Not applicable | Recruiting | Centre Hospitalier Régional d'Orléans | 120 | 2025-01-24 | 2025-12-30 |
| The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV Model of care delivery for long-acting injectable ART - HIV I Infection | Not yet recruiting | MetroHealth Medical Center | 164 | 2024-11-01 | 2024-10-10 | |
| Studying Topiramate for Re-Activating the HIV-1 Reservoir Topiramate - HIV-1-infection, Hiv | Phase 1 / Phase 2 | Unknown | Erasmus Medical Center | 12 | 2024-09-01 | 2024-02-28 |
| Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe Uterine Cervical Neoplasms, HIV I Infection | Active not recruiting | University of Bern | 168 | 2024-05-03 | 2026-06-26 | |
| Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV Doravirine 100 Mg - HIV I Infection, Cardiovascular Risk Factor | Early Phase 1 | Completed | University of Texas Southwestern Medical Center | 26 | 2024-03-01 | 2026-01-30 |
| ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa Community-delivered TB preventive therapy (TPT) - 3 months weekly isoniazid plus rifapentine (3HP), Clinic-link TPT - Tuberculosis, HIV I Infection | Not applicable | Completed | University of Washington | 301 | 2024-02-20 | 2026-07-30 |
| Evaluating the Safety and Immunogenicity of MTBVAC MTBVAC, BCG - HIV I Infection, Tuberculosis | Phase 2 | Recruiting | HIV Vaccine Trials Network | 276 | 2024-01-30 | 2026-10-30 |
| Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy Estradiol - HIV I Infection | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 93 | 2024-01-04 | 2026-04-08 |
| To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV VIR-1388, Placebo - HIV I Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 93 | 2023-09-19 | 2026-03-03 |
| Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis Adalimumab Injection - Tuberculous Meningitis, HIV I Infection | Phase 2 | Recruiting | ANRS, Emerging Infectious Diseases | 130 | 2023-04-11 | 2025-12-15 |
| Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy Nivolumab 10 MG/ML [Opdivo], Saline - HIV I Infection | Phase 1 / Phase 2 | Recruiting | University of Melbourne | 42 | 2023-01-24 | 2025-12-22 |
| A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA CAB + RPV - HIV-1-infection, HIV Infections | Phase 3 | Completed | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 12 | 2023-01-01 | 2026-07-14 |
| A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/ HIV I Infection | Active not recruiting | NEAT ID Foundation | 500 | 2022-10-10 | 2026-04-28 | |
| The Visceral Adiposity Measurement and Observation Study Diagnostic Test, HIV Anti-retroviral Background Therapy - HIV, HIV-Infections | Completed | Theratechnologies | 196 | 2022-04-18 | 2023-11-18 | |
| Effect of a Mobile Health Intervention on Treatment Adherence mobile health (mHealth) - HIV I Infection | Not applicable | Completed | Hospital Civil de Guadalajara | 80 | 2022-04-01 | 2022-11-29 |
| Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa Immediate anti-TB therapy, Sepsis-specific dose anti-TB therapy - Tuberculosis, HIV I Infection | Phase 3 | Completed | University of Virginia | 437 | 2022-01-05 | 2026-09-09 |
| Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI MRI - HIV I Infection, HIV Associated Lipodystrophy | Not applicable | Unknown | University of Novi Sad | 120 | 2021-05-01 | 2021-12-01 |
| Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments Uniform Standard of Care Counseling, Behavioral Self-Regulation Skills Counseling, Behavioral Self-Regulation Skills Counseling + Stigma Management - HIV I Infection | Not applicable | Active not recruiting | University of Connecticut | 3771 | 2021-02-01 | 2025-08-29 |
Showing 20 of 31. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (3) · HIV Infections (3) · Tuberculosis (3) · HIV-Associated Lipodystrophy Syndrome (2) · Cardiovascular Diseases (1) · Fatty Liver (1) · Inflammation (1) · Lipid Metabolism Disorders (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Metabolic Syndrome (1) · Multiple Endocrine Neoplasia Type 1 (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Papillomavirus Infections (1)
Infections (10) · Communicable Diseases (6) · Genital Diseases (6) · Pathological Conditions, Signs and Symptoms (6) · Sexually Transmitted Diseases (6) · Sexually Transmitted Diseases, Viral (6) · Urogenital Diseases (6) · Virus Diseases (6) · Blood-Borne Infections (5) · Immune System Diseases (5) · Immunologic Deficiency Syndromes (5) · Lentivirus Infections (5) · Pathologic Processes (5) · RNA Virus Infections (5) · Retroviridae Infections (5)
Emtricitabine (2) · Vacc-4x (2) · dolutegravir (2) · 9 alpha,11 alpha,15 alpha-trihydroxy-16-phenoxy-17,18,19,20-tetranorprosta-4,5,13-trienoic acid (1) · Adalimumab (1) · Auranofin (1) · Diagnostic Tests, Routine (1) · Estradiol (1) · Hematologic Tests (1) · Lamivudine (1) · MTBVAC vaccine (1) · Maraviroc (1) · Niacinamide (1) · Nivolumab (1) · Sodium Chloride (1)
ANRS, Emerging Infectious Diseases (2) · Bionor Immuno AS (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · Beckman Coulter, Inc. (1) · Biomedical Research and Training Institute, Zimbabwe (1) · Centre Hospitalier Régional d'Orléans (1) · Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida (1) · Charlotte-Paige Rolle, MD (1) · Epividian (1) · Erasmus Medical Center (1) · Federal University of São Paulo (1) · HIV Vaccine Trials Network (1) · Hospital Civil de Guadalajara (1) · MetroHealth Medical Center (1)
United States (13) · France (4) · South Africa (3) · Brazil (2) · Mexico (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · Zimbabwe (2) · Australia (1) · Belgium (1) · Denmark (1) · Germany (1) · Italy (1) · Mozambique (1)
Adrienne E Shapiro, MD, PhD (1) · Anton Pozniak (1) · Charlotte-Paige Rolle, MD (1) · Christopher Moore, MD (1) · Corrilynn O Hileman, MD (1) · Jane O'Halloran, MB BA PhD (1) · Jeffery Carr, DR (1) · John Koethe, MD (1) · Jordan E. Lake, MD, MSc (1) · Jordan Lake, MD (1) · Jorge A. Gallardo-Cartagena, MD (1) · Kimberly K. Scarsi, PharmD, MS, FCCP (1)
PMID 24525316, PMID 26379282, PMID 27658863, PMID 28273627, PMID 28618093, PMID 32720308, PMID 35667721, PMID 35959737, PMID 36330583, PMID 36787296, PMID 37452553, PMID 38985445, PMID 39881127, PMID 40803739, PMID 41619753, PMID 41768988
2023 (1), 5UM1AI068614-18 (1), R21AI179276 (1), R34MH124082 (1), U01AI069924 (1), U01AI150508 (1)